GlassScriptPhysician profile
Monica Ramirez
NPI 1043663735
$9,136.14
in general payments reported to CMS, 2019-2025
24 companies · $2,122 in 2025
The $2,122 reported for 2025 was more than what 95% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $669 · 2022: $1,320 · 2023: $2,570 · 2024: $2,455 · 2025: $2,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,130 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,129.64 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,617.58 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $2,586.78 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,468.40 | 2021-2025 | Ofev, Stiolto Respimat |
| Mallinckrodt Hospital Products INC. | $414.00 | 2021-2025 | Acthar |
| Genzyme Corporation | $336.36 | 2022-2025 | |
| Amgen INC. | $291.23 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $246.06 | 2025 | Ohtuvayre |
| Insmed, INC. | $241.16 | 2024-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $187.20 | 2023-2024 | Nuzyra |
| Ani Pharmaceuticals, INC. | $138.97 | 2023-2024 | Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $119.31 | 2022-2025 | Dupixent |
| Pfizer INC. | $76.29 | 2021-2024 | |
| Advanced Respiratory, INC | $68.48 | 2021 | |
| Mylan Specialty L.P. | $66.49 | 2022-2024 | Yupelri |
| Alexion Pharmaceuticals, INC. | $48.73 | 2022-2023 | Soliris |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $47.57 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Boston Scientific Corporation | $38.80 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.15 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $28.13 | 2025 | Opsumit, Uptravi |
| Viatris Specialty LLC | $25.00 | 2025 | Yupelri |
| Lilly USA, LLC | $20.80 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $19.01 | 2023 | |
| Hikma Pharmaceuticals USA | $15.29 | 2023 | Ryaltris |
| Genentech USA, INC. | $4.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.